GL1X · GenesisL1 explorer

Research workbench

IRAK4 in complex with inhibitor

Analyse IRAK4 in complex with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6F3D
Type
protein
Length
564 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-1 receptor-associated kinase 4
EC
2.7.11.1
UniProt
Q9NWZ3
Ligands
CJT, SO4
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein27941% helix, 18% strandQ9NWZ3
BInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein28541% helix, 19% strandQ9NWZ3

Ligands and binding sites

  • CJT · 4-[4-[[4-(dimethylamino)cyclohexyl]amino]-7~{H}-pyrrolo[2,3-d]pyrimidin-5-yl]cyclohexane-1-carboxamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18130.740.7853empty
24690.710.8143CJT
34550.690.8048CJT
4790.420.7915empty
5590.250.7213empty

Interfaces

1 interface between chains.

  • A–B · 641 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6F3D · IRAK4 IN COMPLEX WITH inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.